US 12384789
Compounds for treating Huntington's disease
granted A61PA61P25/14
Quick answer
US patent 12384789 (Compounds for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P25/14